Antiepileptic medicine utilization in older people over a 9-year study period

Prasad S. Nishtala, Chanaka Kaluarachchi
{"title":"Antiepileptic medicine utilization in older people over a 9-year study period","authors":"Prasad S. Nishtala,&nbsp;Chanaka Kaluarachchi","doi":"10.1016/j.gmhc.2016.04.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The aim of this population-level study was to describe and characterize the utilization of AEDs in older people in New Zealand from 2005 to 2013.</p></div><div><h3>Methods</h3><p>De-identified individual level dispensing data for people aged 65 years and over for the period 2005–2013 were obtained from New Zealand Ministry of Health. AEDs were categorized using the ATC classification system of the WHOCC and Norwegian institute of public health. Utilization rates by year, age, sex, ethnicity and district health boards were measured as DDD per TOPD.</p></div><div><h3>Results</h3><p><span>The prevalence of AEDs utilization (DDD/TOPD) increased from 14.23 in 2005 to 14.39 in 2013. The newer AEDs increased from 0.64 in 2005 to 1.82 in 2013, but the prevalence for older AEDs decreased over the same study period from 13.59 to 12.57. AEDs utilization in males over the 9-year period was 17.18 (33.22% higher than females). Highest utilization was observed in those aged between 65 and 69 years, with average of 15.44 (28.88% higher than 85 plus age group). Sodium valproate<span> followed by phenytoin and </span></span>carbamazepine<span> were the most common AEDs. Among the newer AEDs, gabapentin<span> followed by lamotrigine was most frequently utilized.</span></span></p></div><div><h3>Conclusion</h3><p>Utilization of AEDs increased over the 9-year study period in older New Zealanders. The newer AEDs may have contributed to this increase. Further research is required to examine the utilization of AEDs by therapeutic indications.</p></div>","PeriodicalId":100583,"journal":{"name":"Geriatric Mental Health Care","volume":"3 3","pages":"Pages 41-46"},"PeriodicalIF":0.0000,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmhc.2016.04.001","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Geriatric Mental Health Care","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212969315300021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The aim of this population-level study was to describe and characterize the utilization of AEDs in older people in New Zealand from 2005 to 2013.

Methods

De-identified individual level dispensing data for people aged 65 years and over for the period 2005–2013 were obtained from New Zealand Ministry of Health. AEDs were categorized using the ATC classification system of the WHOCC and Norwegian institute of public health. Utilization rates by year, age, sex, ethnicity and district health boards were measured as DDD per TOPD.

Results

The prevalence of AEDs utilization (DDD/TOPD) increased from 14.23 in 2005 to 14.39 in 2013. The newer AEDs increased from 0.64 in 2005 to 1.82 in 2013, but the prevalence for older AEDs decreased over the same study period from 13.59 to 12.57. AEDs utilization in males over the 9-year period was 17.18 (33.22% higher than females). Highest utilization was observed in those aged between 65 and 69 years, with average of 15.44 (28.88% higher than 85 plus age group). Sodium valproate followed by phenytoin and carbamazepine were the most common AEDs. Among the newer AEDs, gabapentin followed by lamotrigine was most frequently utilized.

Conclusion

Utilization of AEDs increased over the 9-year study period in older New Zealanders. The newer AEDs may have contributed to this increase. Further research is required to examine the utilization of AEDs by therapeutic indications.

一项为期9年的老年人抗癫痫药物使用研究
本研究的目的是描述2005年至2013年新西兰老年人使用aed的情况。方法从新西兰卫生部获得2005-2013年65岁及以上人群的个人层面配药数据。采用世界卫生组织和挪威公共卫生研究所的ATC分类系统对aed进行分类。按年份、年龄、性别、种族和地区卫生局分列的使用率以每日每日用药/总每日用药来衡量。结果该院抗癫痫药使用率(DDD/TOPD)由2005年的14.23上升至2013年的14.39。新aed的患病率从2005年的0.64上升到2013年的1.82,但在同一研究期间,旧aed的患病率从13.59下降到12.57。9年期间,男性使用aed的比率为17.18%(比女性高33.22%)。65 ~ 69岁人群的使用率最高,平均为15.44,比85岁以上人群高28.88%。丙戊酸钠其次是苯妥英和卡马西平是最常见的AEDs。在较新的aed中,加巴喷丁和拉莫三嗪最常被使用。结论:在为期9年的研究期间,新西兰老年人对aed的使用有所增加。较新的aed可能促成了这一增长。需要进一步的研究来检查抗癫痫药的治疗指征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信